Evidence statement

Level of evidenceEvidence statement
Level 1+ to 2The evidence suggests that olanzapine (i/m) is safe and effective for rapid tranquillisation for service users with schizophrenia. However the study population did not necessarily require rapid tranquillisation. The evidence suggests olanzapine (i/m) has fewer side effects and is more rapid in onset than (i/m) haloperidol.

From: 7, Methods and findings

Cover of Violence
Violence: The Short-Term Management of Disturbed/Violent Behaviour in In-Patient Psychiatric Settings and Emergency Departments.
NICE Clinical Guidelines, No. 25.
National Collaborating Centre for Nursing and Supportive Care (UK).
Copyright © 2006, Royal College of Nursing.

All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means electronic,mechanical, photocopying, recording or otherwise,without prior permission of the Publishers or a licence permitting restricted copying issued by the Copyright Licensing Agency, 90 Tottenham Court Road, London W1T 4LP. This publication may not be lent, resold, hired out or otherwise disposed of by ways of trade in any form of binding or cover other than that in which it is published,without the prior consent of the Publishers.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.